Joint partners forum for strengthening and aligning tb diagnosis and treatment



Yüklə 430.89 Kb.
səhifə1/20
tarix28.10.2017
ölçüsü430.89 Kb.
  1   2   3   4   5   6   7   8   9   ...   20


WHO Executive Board Room Geneva, 27-30 April 2015

GLI / GDI Partners Forum

Organized by the World Health Organization

Global TB Programme

d:\dropbox\gli gdi meeting april 2015\7_edited-4651.jpg
JOINT PARTNERS FORUM FOR STRENGTHENING AND ALIGNING

TB DIAGNOSIS AND TREATMENT

JOINT PARTNERS FORUM FOR STRENGTHENING AND ALIGNING TB DIAGNOSIS AND TREATMENT

REPORT


27-30 April 2015

Geneva, Switzerland


Contents


List of abbreviations 4

Background 5

Session 1: Introduction 6

Session 2: Advancements and opportunities in diagnosis and treatment 9

Session 3: Introduction and access to new anti-TB drugs 12

Session 4: Implementing innovations 18

Session 5: Update on Xpert MTB/RIF implementation 22

Session 6: Joint TB and HIV services platforms and opportunities for TB/HIV integration 25

Session 7: Country Experiences in strengthening and aligning diagnosis and treatment 28

Session 8: Donor perspectives and strategies to strengthen and align diagnosis and treatment 33

Session 9: Initiatives to strengthen PMDT 36

Session 10: Symposium on regional GLI/GDI initiatives 39

List of participants 44

Photos cortesy of Ernesto Jaramillo and Medea Gegia



All presentations from the meeting are posted on the WHO website http://www.who.int/tb/laboratory/gli/en/


List of abbreviations





ARV

antiretroviral

Bdq

Bedaquiline

BRICS

Brazil, Russia, India, China and South Africa

CEM

cohort event monitoring

CHAI

Clinton Health Access Initiative

CoE

Centers of Excellence

CU

Compassionate Use

CXR

chest x-ray

DCS

Dried culture spot

Dlm

Delamanid

DR-TB

drug-resistant tuberculosis

DST

drug –susceptibility testing

EQA

External Quality Assessment

ERS

European Respiratory Society

FDC

fixed-dose combination

FIND

Foundation for Innovative New Diagnostics

GDF

Global Drug Facility

GDI

Global Drug resistant TB Initiative

GLI

Global Laboratory Initiative

GSM

Global System for Mobile Communications

GTB

Global TB Programme

HSP

Human Spirit Project

IRD

Interactive Research and Development

LAM

lipoarabinomannan

LAMP

Loop mediated isothermal amplification

LMICs

Lower middle income countries

LPA

Line probe assay

LTBI

latent tuberculosis infection

MDR-TB

multidrug-resistant tuberculosis

NAAT

nucleic acid amplification test

NFM

New Funding Model

NTP

National TB Programme

PEPFAR

United States President’s Emergency Plan for AIDS Relief

PLHIV

People living with HIV/AIDS

PMDT

programmatic management of drug-resistant tuberculosis

POC

Point-of-care

PV

Pharmacovigilance

QMS

quality management system

RESIST TB

Research Excellence to Stop TB Resistance

rGLC

regional Green Light Committee

RR-TB

Rifampicin resistant tuberculosis

SCM

Supply Chain Management

SLD

second-line drugs

SLIPTA

Strengthening Laboratory Management Towards Accreditation

SLMTA

Stepwise Laboratory Quality Improvement Process Towards Accreditation

SRL

Supranational Reference Laboratory

STAT

Scale-up Treatment Action Team

SWIFT

Society Working on Implementation to Fight TB

TB

tuberculosis

TB/HIV

tuberculosis/human immunodeficiency virus

TPP

target product profile

TRP

Technical Review Panel

UNITAID

Innovative Financing to Shape Markets for HIV/AIDS, Malaria and Tuberculosis

USAID

United States Agency for international Development

VL

Viral load

WHO

World Health Organization

XDR -TB

Extensively drug-resistant tuberculosis


Dostları ilə paylaş:
  1   2   3   4   5   6   7   8   9   ...   20


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2017
rəhbərliyinə müraciət

    Ana səhifə